Practice and benefit of national standardized management of type 2 diabetes in Yulin City

Jie HU; Feng Zhang; Xingmei LI; Yanni Wang; Fuxiang Shi; Shaojuan Feng; Puliufang HE; Xiumei Zhang; Hui Zhao; Qiaofen Yang; Rui Song; Xiuxiu Feng; Jiansheng Niu

Return

Practice and benefit of national standardized management of type 2 diabetes in Yulin City

VernacularTitle:国家标准化管理2型糖尿病患者榆林实践及获益研究
Author: Jie HU ^{1
,

2} ; Feng ZHANG ^{1
,

2} ; Xingmei LI ^{1
,

2} ; Yanni WANG ^{1
,

2} ; Fuxiang SHI ^{1
,

2} ; Shaojuan FENG ^{1
,

2} ; Puliufang HE ^{1
,

2} ; Xiumei ZHANG ^{1
,

2} ; Hui ZHAO ^{1
,

2} ; Qiaofen YANG ^{1
,

2} ; Rui SONG ^{1
,

2} ; Xiuxiu FENG ^{1
,

2} ; Jiansheng NIU ^{1
,

2}
Author Information

1. Yulin Branch of The First Affiliated Hospital, Xi’an Jiaotong University
2. Yulin No. 2 Hospital, Yulin 719000, China
Publication Type:Journal Article
Keywords: National Metabolic Management Center (MMC); type 2 diabetes mellitus; glycemic control; rate of control
From: Journal of Xi'an Jiaotong University(Medical Sciences) 2023;44(5):836-840
CountryChina
Language:Chinese
Abstract: 【Objective】 To investigate the practice and benefit of national standardized management of type 2 diabetes in Yulin City. 【Methods】 We recruited the adult type 2 diabetes patients who sought medical help at our hospital from May 2020 to October 2022 as subjects. We collected their basic information (sex and age); measured height, weight, waist and hip circumference, and blood pressure; calculated body mass index (BMI); and detected blood glucose, c-peptide, HbA1c, biomarkers, urinary microalbumin, sensory nerve conduction velocity of lower limbs, ABI, and subcutaneous and visceral fat at the time of MMC recruited and the end of six months. T test and Mann-Whitney U rank sum test were used for measurement data and χ² test or Fisher’s exact probability method for counting data to analyze the data. 【Results】 After 6 months, the levels of fasting blood glucose, postprandial blood glucose, HbA1c, and visceral and subcutaneous fat in all the patients decreased, but the level of fasting c-peptide increased compared with the baseline (all P<0.05). Secondly, compared with the baseline, the control rate of HbA1c (35.21% vs. 13.71% ) and the comprehensive control rate (13.97% vs. 7.26% ) were both significantly increased at six months (P<0.05). Thirdly, after 6 months, the levels of fasting blood glucose, postprandial blood glucose, HbA1c, TG, TC, and UA were decreased more, while the fasting c-peptide and postprandial c-peptide were increased more in the patients of the HbA1c standard group (HbA1c<7% ) than those of the non-standard group. 【Conclusion】 The multiple benefits of blood glucose, blood lipid, uric acid and islet function can be achieved by taking type 2 diabetes patients into MMC. Meanwhile, the rates of HbA1c control and comprehensively reaching the standard are significantly increased. Therefore, MMC can explore a new way for the management of type 2 diabetic patients in this area.